cbdMD, Inc. (NYSEAMERICAN:YCBD) Short Interest Down 49.7% in March

cbdMD, Inc. (NYSEAMERICAN:YCBD) was the target of a significant decline in short interest during the month of March. As of March 13th, there was short interest totaling 554,205 shares, a decline of 49.7% from the February 26th total of 1,102,343 shares. Based on an average trading volume of 516,984 shares, the days-to-cover ratio is currently 1.1 days. Approximately 5.6% of the company’s stock are sold short.

cbdMD Stock Down 6.0%

Shares of YCBD stock traded down $0.05 on Thursday, reaching $0.76. The stock had a trading volume of 817,716 shares, compared to its average volume of 469,181. The firm’s 50-day moving average is $0.81 and its two-hundred day moving average is $0.92. cbdMD has a 12 month low of $0.47 and a 12 month high of $3.36.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in cbdMD stock. Jane Street Group LLC bought a new stake in cbdMD, Inc. (NYSEAMERICAN:YCBD) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 51,141 shares of the company’s stock, valued at approximately $69,000. Jane Street Group LLC owned about 0.49% of cbdMD at the end of the most recent quarter. Hedge funds and other institutional investors own 7.18% of the company’s stock.

cbdMD Company Profile

cbdMD, Inc (NYSEAMERICAN: YCBD) is a Charlotte, North Carolina–based producer and distributor of hemp-derived cannabidiol (CBD) products. Since its founding in 2018, the company has focused on developing a diverse portfolio of wellness offerings designed for human and pet use. Its product range includes tinctures, capsules, gummies, topicals, and pet-specific formulations, each developed to comply with U.S. Food and Drug Administration (FDA) guidelines for hemp-derived substances.

The company operates a vertically integrated business model, sourcing U.S.-grown hemp and overseeing manufacturing processes in cGMP-certified facilities.